array cgh Search Results


90
CombiMatrix array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh, supplied by CombiMatrix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc03751902-83-3-14?v=CombiMatrix
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Enzo Biochem cgh labeling kit for oligo arrays enzo 42671
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Cgh Labeling Kit For Oligo Arrays Enzo 42671, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc04416090-103-20-22?v=Enzo+Biochem
Average 90 stars, based on 1 article reviews
cgh labeling kit for oligo arrays enzo 42671 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BlueGnome Limited 24-h array-cgh protocol
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
24 H Array Cgh Protocol, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc04717135-123-1-21?v=BlueGnome+Limited
Average 90 stars, based on 1 article reviews
24-h array-cgh protocol - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
PreventionGenetics llc gene-centric array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Gene Centric Array Cgh, supplied by PreventionGenetics llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc06014458__MGG3___6___434___s001-35-6-17?v=PreventionGenetics+llc
Average 90 stars, based on 1 article reviews
gene-centric array cgh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Integragen sa bac-arrays igv7 (5878 bacs)
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Bac Arrays Igv7 (5878 Bacs), supplied by Integragen sa, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pm24559140-78-18-12?v=Integragen+sa
Average 90 stars, based on 1 article reviews
bac-arrays igv7 (5878 bacs) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
SYGNIS AG array-cgh experiments
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh Experiments, supplied by SYGNIS AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc05024699-409-35-27?v=SYGNIS+AG
Average 90 stars, based on 1 article reviews
array-cgh experiments - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Oxford Gene Technology array-cgh analysis
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh Analysis, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc07310047-79-0-5?v=Oxford+Gene+Technology
Average 90 stars, based on 1 article reviews
array-cgh analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Institute for Clinical Pharmacodynamics custom array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Custom Array Cgh, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pm31029168-266-10-2?v=Institute+for+Clinical+Pharmacodynamics
Average 90 stars, based on 1 article reviews
custom array cgh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Beratung GmbH vergleichende genomische hybridisierung (array-cgh)
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Vergleichende Genomische Hybridisierung (Array Cgh), supplied by Beratung GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pm30001568-39-2-1?v=Beratung+GmbH
Average 90 stars, based on 1 article reviews
vergleichende genomische hybridisierung (array-cgh) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BlueGnome Limited array cgh
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pm30922649-55-0-7?v=BlueGnome+Limited
Average 90 stars, based on 1 article reviews
array cgh - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
NimbleGen Systems GmbH high-resolution whole genome cgh analysis
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
High Resolution Whole Genome Cgh Analysis, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/10__1203_slash_pdr__0b013e31818095d0-83-10-5?v=NimbleGen+Systems+GmbH
Average 90 stars, based on 1 article reviews
high-resolution whole genome cgh analysis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Eurogenetica Ltd array cgh resolution platforms
Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma
Array Cgh Resolution Platforms, supplied by Eurogenetica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/array+cgh/pmc06777611-435-9-45?v=Eurogenetica+Ltd
Average 90 stars, based on 1 article reviews
array cgh resolution platforms - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma

Journal: Orphanet Journal of Rare Diseases

Article Title: Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

doi: 10.1186/1750-1172-8-112

Figure Lengend Snippet: Summary of molecular profiling analyses from various CLIA certified methods in a patient with malignant phyllodes sarcoma

Article Snippet: Whole-genome array-based comparative genomic hybridization (array CGH) was performed by using the CLIA-certified DNAarrayTM (CombiMatrix Diagnostics, Irvine, CA).

Techniques: Sequencing, Hybridization, Immunohistochemistry, Staining

Imaging studies, histopathology and FISH studies: UA and B: CT of the chest showing metastatic masses in the lung. C Hematoxylin and Eosin stained section of the tumor from the right mastectomy shows a malignant sarcoma/malignant phyllodes tumor that has high stromal cellularity and a mitotic index of 11 per 10 high power fields. D HER - 2 / neu by Fluorescence in Situ Hybridization (FISH) HER-2 gene amplification was assessed utilizing the PathVysion assay (Vysis Corp., Downers Grove, Illinois). The identification probes for the HER-2 (SpectrumOrange) and alpha satellite DNA sequence at the centromeric region of chromosome 17 (SpectrumGreen) were hybridized according to the manufacturer’s guidelines. At least twenty non-overlapping nuclei containing at least one orange and one green signal were enumerated. The ratio of orange signals (HER-2 gene) to green signals (chromosome 17) was calculated. A ratio greater than or equal to 2.0 is considered as amplified based on the FDA approval in this kit. The CAP HER-2 consensus conference 2002 suggested that a ratio of 1.8-2.2 be considered as borderline.

Journal: Orphanet Journal of Rare Diseases

Article Title: Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities

doi: 10.1186/1750-1172-8-112

Figure Lengend Snippet: Imaging studies, histopathology and FISH studies: UA and B: CT of the chest showing metastatic masses in the lung. C Hematoxylin and Eosin stained section of the tumor from the right mastectomy shows a malignant sarcoma/malignant phyllodes tumor that has high stromal cellularity and a mitotic index of 11 per 10 high power fields. D HER - 2 / neu by Fluorescence in Situ Hybridization (FISH) HER-2 gene amplification was assessed utilizing the PathVysion assay (Vysis Corp., Downers Grove, Illinois). The identification probes for the HER-2 (SpectrumOrange) and alpha satellite DNA sequence at the centromeric region of chromosome 17 (SpectrumGreen) were hybridized according to the manufacturer’s guidelines. At least twenty non-overlapping nuclei containing at least one orange and one green signal were enumerated. The ratio of orange signals (HER-2 gene) to green signals (chromosome 17) was calculated. A ratio greater than or equal to 2.0 is considered as amplified based on the FDA approval in this kit. The CAP HER-2 consensus conference 2002 suggested that a ratio of 1.8-2.2 be considered as borderline.

Article Snippet: Whole-genome array-based comparative genomic hybridization (array CGH) was performed by using the CLIA-certified DNAarrayTM (CombiMatrix Diagnostics, Irvine, CA).

Techniques: Imaging, Histopathology, Staining, Fluorescence, In Situ Hybridization, Amplification, Sequencing